8Dellinger RP,Levy MM,Carlet JM,et al.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock:2008[J].Crit Care Med,2008,36(1):296-327.
9Vivian B,Audrev S,Inna K,et al.Prevalence of hypophosphatemia in sepsis and infection:the mle of cytokines[J].Am J Med,1998,104:4047.
7Montravers P,Lepape A,Dubreuil L,et al.Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections:results of the French prospective,observational EBIIA study.J Antimicrob Chemother,2009,63(4):785-794.
8Annane D,Aegerter P,Jars-Guincestre MC,et al.Current Epidemiology of Septic Shock:The CUB-Réa Network.Am J Respir Crit Care Med,2003,168(2):165-172.
9Weigelt JA.Empiric treatment options in the management of complicated intra-abdominal infections.Cleve Clin J Med,2007,74(Suppl 4):s29-s37.
10]Dellinger RP,Carlet JM,Masur H,et al.Surviving sepsis campaign guidelines for management of severe sepsis and septic shock.Intensive Care Med,2004,30(4):536-555.
